Energy Transfer: Strong Buy With A Path To 7% Yield On Cost

Energy Transfer reiteration/upgrade support is driven by a 6.3% yield and a guidance raise: 2026 EBITDA guidance was lifted to $18.8–$19.1B. Q2 partner-attributable DCF rose 32% and first-half conventional free cash flow grew 49%, with distribution coverage staying above 2.2x, signaling strong cash generation and coverage. The diversified, fee-based model and large contracted backlog improve visibility into future earnings, supporting the “strong buy” stance.

Analysis

ET’s edge here is not the headline payout; it is the shift from “income story” to “self-funded growth + income.” When a midstream name is producing materially more cash than it is distributing and still raising forward EBITDA, the equity usually rerates through the denominator: lower perceived financing risk, lower equity dilution risk, and a smaller discount rate on future distributions. That is constructive not just for ET, but for the cleaner fee-based complex such as EPD, MPLX, and WMB, while more levered or more commodity-sensitive names should lag because they still need favorable capital markets to fund expansion.

The near-term catalyst is revisions, not the print itself. In the next 1-3 months, the stock should respond to whether sell-side models actually ratchet up free cash flow and distribution growth assumptions, and whether management keeps capex discipline intact. The key falsifier is any evidence that the growth backlog demands more capital than expected, because then the market will look through the coverage ratio and reapply a leverage discount. Over 6-18 months, backlog monetization can support a higher payout and buybacks, but rate volatility remains the main ceiling on multiple expansion.

The consensus risk is that investors treat ET like a simple yield bond and miss the option value embedded in persistent excess cash generation. If that cash is real, the re-rating can persist longer than expected; if it is front-loaded or capex-heavy, the move is overdone. My bias is that the fundamental improvement is real, but the market may already be partially pricing it, so the better expression may be relative value rather than chasing absolute upside.

Key Decisions for Investors

• Add ET on weakness over the next 1-2 weeks as a core 6-18 month income-plus-growth hold; thesis weakens if forward EBITDA slips below the current raised range or coverage trends materially below ~2.0x.
• Run a relative-value long ET / short KMI basket for 3-6 months to express stronger self-funding and backlog visibility versus a slower-growth midstream peer; close if the sector broadly rerates on inflows rather than fundamentals.
• If you want basket exposure with lower single-name risk, buy AMLP/AMLP-equivalent MLP exposure and use ET as the highest-conviction overweight; this captures sector rerating if income capital rotates back into midstream.
• Set a take-profit alert if the yield compresses aggressively while the 10-year Treasury keeps rising; in that scenario, multiple expansion becomes rate-sensitive and the upside/risk skews less favorable.